Company patents
Novaled GmbH
Novaled GmbH, while heavily focused on Organic Electronics (OLED) with 91.4% of its portfolio, surprisingly shows a significant and emerging interest in pharma_biotech, with Heterocyclic Compounds growing by 85.7% in 2025 and Acyclic / Carbocyclic Compounds by 150.0% in the same year, despite a general decline in patenting activity across most categories so far in 2026. This suggests a strategic diversification beyond its core display technology into pharmaceutical compounds, while its legacy Specialty Semiconductor Devices have seen a complete cessation of patenting since 2024.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
105 US filings (since 2023) · 7 categories · 5 themes
Development and optimization of organic chemical compounds and their structures, including guest-host systems and metal complexes, used within the emission layer to achieve specific light emission characteristics such as color, efficiency, and operational lifetime.
Synthesis and application of organic compounds designed to impart specific functionalities in material science, such as photosensitivity or charge transport, for electronic or optical devices.
Techniques and structural designs for fabricating the physical layers of an OLED display, including material deposition, patterning, and methods to protect the active organic layers from environmental degradation like moisture and oxygen.
Methods and structures for incorporating touch sensing capabilities directly into OLED display panels, typically involving conductive layers and insulating layers within or on top of the display stack.
Components and techniques aimed at improving the visual quality of OLED displays, such as color accuracy, contrast, brightness uniformity, and reducing reflections or glare through optical layers and coatings.
Patents
Showing 1-10 of 174